NCT06200753

Brief Summary

The objective of this study is to create a comprehensive, multi-center, TRACK-LVO registry-linked cohort of consecutive patients with acute ischemic stroke (AIS) caused by large vessel occlusions (LVO) and presenting to each participating center beyond 24 hours from last known well, who are treated with either endovascular therapy (EVT) or the best available medical management (BMM).

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,000

participants targeted

Target at P75+ for all trials

Timeline
32mo left

Started Jan 2018

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress76%
Jan 2018Dec 2028

Study Start

First participant enrolled

January 1, 2018

Completed
6 years until next milestone

First Submitted

Initial submission to the registry

December 16, 2023

Completed
26 days until next milestone

First Posted

Study publicly available on registry

January 11, 2024

Completed
5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2028

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2028

Last Updated

January 11, 2024

Status Verified

December 1, 2023

Enrollment Period

11 years

First QC Date

December 16, 2023

Last Update Submit

December 30, 2023

Conditions

Keywords

Acute Ischemic Stroke, Endovascular Therapy,

Outcome Measures

Primary Outcomes (2)

  • Modified ranking scale (mRS) at 90 days

    A 0-6 scale running from perfect health without symptoms to death.

    90 days

  • symptomatic intracranial hemorrhage

    any hemorrhagic transformation on subsequent imaging associated with a neurological decline of at least 4 points increase on the NIHSS score

    72 hours

Secondary Outcomes (3)

  • National Institutes of Health Stroke Scale (NIHSS) scores at 90 days

    1, 3, 5 (or discharge), 7 (or discharge) and 90 days

  • Occurrence of periprocedural complications

    72 hours

  • EuroQol five dimensions questionnaire (EQ-5D)

    1 year

Study Arms (2)

Endovascular therapy

Procedure: Mechanical Thrombectomy

Best medical treatment

Procedure: Mechanical Thrombectomy

Interventions

Mechanical Thrombectomy: A stroke treatment method involving the use of a device to extract a blood clot from the blood vessels, restoring blood flow and reducing brain damage. Ischemic Post-conditioning: After thrombectomy, a procedure involving inflating and deflating a balloon in situ for four cycles of 2 minutes each, reducing reperfusion injury and minimizing neural damage. Selective Hypothermia: Administering cold saline either intra-arterially or within the cerebral sinus to lower brain temperature, mitigating ischemia-induced injury.

Also known as: Ischemic post-conditioning, Selective Hypohermia
Best medical treatmentEndovascular therapy

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Acute stroke patients with large vessel occlusion and presenting beyond 24 hours from last known well

You may qualify if:

  • Patient admitted from Jan. 1st 2018 to Jan. 1st 2028;
  • Presenting beyond 24 hours from last known well;
  • Ischemic stroke confirmed by head CT or MRI;
  • Large vessel occlusion confirmed by head CTA or MRA: intracranial internal carotid artery (ICA), middle cerebral artery (MCA M1/M2), anterior cerebral artery (ACA A1/A2), basilar artery (BA), vertebral artery (VA), and posterior cerebral artery (PCA P1/P2);
  • Patients receiving either endovascular therapy or best medical treatment.

You may not qualify if:

  • Presence of any forms of cerebral hemorrhage on CT/MR at admission.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Tianjin Huanhu Hospital

Tianjin, Tianjin Municipality, 300070, China

RECRUITING

MeSH Terms

Conditions

Ischemic Stroke

Interventions

Ischemic Postconditioning

Condition Hierarchy (Ancestors)

StrokeCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Therapeutics

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Chief Physician

Study Record Dates

First Submitted

December 16, 2023

First Posted

January 11, 2024

Study Start

January 1, 2018

Primary Completion (Estimated)

December 31, 2028

Study Completion (Estimated)

December 31, 2028

Last Updated

January 11, 2024

Record last verified: 2023-12

Data Sharing

IPD Sharing
Will not share

Locations